Colgate-Palmolive Co. (NYSE:CL) insider Patricia Verduin sold 3,834 shares of the company’s stock in a transaction dated Thursday, September 15th. The stock was sold at an average price of $71.85, for a total value of $275,472.90. Following the completion of the sale, the insider now owns 55,013 shares of the company’s stock, valued at approximately $3,952,684.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Patricia Verduin also recently made the following trade(s):

  • On Friday, July 15th, Patricia Verduin sold 3,666 shares of Colgate-Palmolive stock. The stock was sold at an average price of $74.98, for a total value of $274,876.68.

Shares of Colgate-Palmolive Co. (NYSE:CL) opened at 73.00 on Thursday. The company has a market cap of $65.08 billion, a PE ratio of 47.01 and a beta of 0.59. Colgate-Palmolive Co. has a 12 month low of $61.40 and a 12 month high of $75.38. The firm’s 50-day moving average price is $73.90 and its 200 day moving average price is $72.09.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Thursday, July 28th. The company reported $0.70 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.69 by $0.01. The business had revenue of $3.85 billion for the quarter, compared to analysts’ expectations of $3.86 billion. Colgate-Palmolive had a return on equity of 1,980.28% and a net margin of 9.04%. The business’s revenue for the quarter was down 5.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.70 EPS. Equities research analysts anticipate that Colgate-Palmolive Co. will post $2.79 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 15th. Stockholders of record on Monday, October 24th will be issued a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a dividend yield of 2.14%. The ex-dividend date is Thursday, October 20th. Colgate-Palmolive’s dividend payout ratio is currently 100.65%.

Several hedge funds and other institutional investors have recently modified their holdings of CL. Krilogy Financial LLC boosted its position in Colgate-Palmolive by 3.2% in the second quarter. Krilogy Financial LLC now owns 1,504 shares of the company’s stock worth $110,000 after buying an additional 46 shares in the last quarter. Tompkins Financial Corp boosted its position in Colgate-Palmolive by 121.1% in the second quarter. Tompkins Financial Corp now owns 1,698 shares of the company’s stock worth $124,000 after buying an additional 930 shares in the last quarter. Arcadia Investment Management Corp MI boosted its position in Colgate-Palmolive by 28.6% in the second quarter. Arcadia Investment Management Corp MI now owns 1,800 shares of the company’s stock worth $132,000 after buying an additional 400 shares in the last quarter. FCM Investments TX acquired a new position in Colgate-Palmolive during the second quarter worth approximately $132,000. Finally, Orrstown Financial Services Inc. boosted its position in Colgate-Palmolive by 26.7% in the second quarter. Orrstown Financial Services Inc. now owns 2,280 shares of the company’s stock worth $167,000 after buying an additional 480 shares in the last quarter. Institutional investors and hedge funds own 72.97% of the company’s stock.

CL has been the subject of a number of recent analyst reports. Atlantic Securities initiated coverage on Colgate-Palmolive in a research note on Wednesday, June 1st. They issued an “overweight” rating for the company. Goldman Sachs Group Inc. reaffirmed a “neutral” rating and issued a $76.00 price objective (up previously from $74.00) on shares of Colgate-Palmolive in a research note on Friday, July 15th. Deutsche Bank AG reaffirmed a “hold” rating and issued a $75.00 price objective (up previously from $73.00) on shares of Colgate-Palmolive in a research note on Sunday, July 24th. B. Riley reaffirmed a “neutral” rating and issued a $71.00 price objective on shares of Colgate-Palmolive in a research note on Friday, July 29th. Finally, BNP Paribas lowered Colgate-Palmolive from an “outperform” rating to a “neutral” rating and set a $76.00 price objective for the company. in a research note on Friday, July 29th. Fifteen analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $74.46.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

5 Day Chart for NYSE:CL

Receive News & Ratings for Colgate-Palmolive Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Co. and related companies with MarketBeat.com's FREE daily email newsletter.